Mathias Schmidt
Overview
Explore the profile of Mathias Schmidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1387
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mansoor K, Mallah E, Abuqatouseh L, Darwish D, Abdelmalek S, Yasin M, et al.
Curr Pharm Teach Learn
. 2025 Jan;
17(5):102297.
PMID: 39889461
Objective: The present study aimed to evaluate pharmacy students' awareness of Complementary and Alternative Medicine (CAM) to highlight the strengths and weaknesses that need improving in the pharmacy curriculum regarding...
2.
Contreras R, Gruber T, Gonzalez-Garcia I, Schriever S, De Angelis M, Mallet N, et al.
Mol Metab
. 2024 Sep;
90:102033.
PMID: 39304061
With age, metabolic perturbations accumulate to elevate our obesity burden. While age-onset obesity is mostly driven by a sedentary lifestyle and high calorie intake, genetic and epigenetic factors also play...
3.
Nakamura K, Sakai N, Hossain M, Eisengart J, Yamamoto T, Tanizawa K, et al.
Orphanet J Rare Dis
. 2024 Mar;
19(1):104.
PMID: 38454486
Background: Mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is a rare X-linked metabolic disorder predominantly affecting males. Pabinafusp alfa, an iduronate-2-sulfatase enzyme designed to cross the blood-brain barrier, was...
4.
Harmatz P, Giugliani R, Martins A, Hamazaki T, Kubo T, Kira R, et al.
Mol Ther
. 2024 Jan;
32(3):609-618.
PMID: 38204164
Mucopolysaccharidosis type I (MPS I) causes systemic accumulation of glycosaminoglycans due to a genetic deficiency of α-L-iduronidase (IDUA), which results in progressive systemic symptoms affecting multiple organs, including the central...
5.
Schmidt M, Wilhelmy S
Dtsch Med Wochenschr
. 2023 Dec;
148(24-25):1583-1588.
PMID: 38052223
No abstract available.
6.
Mansoor K, Aburjai T, Al-Mamoori F, Schmidt M
Phytother Res
. 2023 Sep;
37(12):5755-5768.
PMID: 37770185
The use of plants as a source of active principles for cosmetics has significantly increased in the last few years. Safety, compatibility with all types of skin, fewer side effects,...
7.
Hrvat A, Schmidt M, Wagner B, Zwanziger D, Kimmig R, Volbracht L, et al.
J Exp Clin Cancer Res
. 2023 Sep;
42(1):235.
PMID: 37684704
Background: Malignant ascites commonly occurs in advanced or recurrent stages of epithelial ovarian cancer during peritoneal carcinomatosis and is correlated with poor prognosis. Due to its complex composition of cellular...
8.
Knaup F, Meyners C, Sugiarto W, Wedel S, Springer M, Walz C, et al.
J Med Chem
. 2023 Apr;
66(8):5965-5980.
PMID: 37058391
In recent years, the selective inhibition of FKBP51 has emerged as a possible treatment for chronic pain, obesity-induced diabetes, or depression. All currently known advanced FKBP51-selective inhibitors, including the widely...
9.
Mansoor K, Bardees R, Alkhawaja B, Mallah E, Abuqatouseh L, Schmidt M, et al.
Molecules
. 2023 Mar;
28(5).
PMID: 36903363
The L. (pomegranate) fruit juice contains large amounts of polyphenols, mainly tannins such as ellagitannin, punicalagin, and punicalin, and flavonoids such as anthocyanins, flavan-3-ols, and flavonols. These constituents have high...
10.
Gross D, Schmidt M, Engels P, Kaiser S
Fortschr Neurol Psychiatr
. 2022 Nov;
92(4):121-127.
PMID: 36446605
Aim Of The Study: The focus of this article is the psychiatrist Johann Recktenwald (1882-1964) who has so far received little attention: acquitted of the charge of "crimes against humanity",...